Söreskog, E.
Borgström, F.
Lindberg, I. http://orcid.org/0000-0002-6549-6065
Ström, O.
Willems, D.
Libanati, C.
Kanis, J. A.
Stollenwerk, B.
Charokopou, M.
Funding for this research was provided by:
UCB
Amgen
Article History
Received: 31 July 2020
Accepted: 25 November 2020
First Online: 7 January 2021
Compliance with ethical standards
:
: J.A.K. reports grants from Amgen, Eli Lilly and Radius Health and consulting fees from Theramex. J.A.K. is the architect of FRAX® but has no financial interest. E.S., I.L., F.B. and O.S. are employees of Quantify Research which was contracted and paid by UCB, a pharmaceutical company marketing products for osteoporosis, to conduct the study. The authors did not receive direct payment as a result of this work outside of their normal salary payments. D.W., C.S. and M.C. are employees of UCB Pharma. B.S. is an employee of Amgen (Europe).
: Not applicable.